Company Filing History:
Years Active: 2013
Title: Kristina Hedbacker: Innovator in Diabetes Treatment
Introduction
Kristina Hedbacker is a notable inventor based in New York, NY, who has made significant contributions to the field of diabetes treatment. With a focus on insulin-like growth factor binding proteins, her work aims to improve the lives of individuals suffering from various forms of diabetes.
Latest Patents
Kristina Hedbacker holds one patent titled "Methods and kits for treating disease by administering insulin-like growth factor binding protein-2." This invention outlines methods for treating Type 1 and Type 2 diabetes by administering a therapeutically effective amount of Insulin-like Growth Factor-binding protein-2. Additionally, her patent addresses treatments for insulin resistance and hepatic steatosis, as well as methods for lowering blood glucose and serum insulin levels in non-diabetic subjects.
Career Highlights
Hedbacker is affiliated with The Rockefeller University, where she conducts her research and develops innovative treatments. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.
Collaborations
One of her notable collaborators is Jeffrey M. Friedman, who shares her dedication to research in the field of diabetes and metabolic disorders.
Conclusion
Kristina Hedbacker's contributions to diabetes treatment through her innovative patent demonstrate her commitment to advancing medical science. Her work continues to inspire and pave the way for future research in this critical area of health.